Topical chemotherapy for ocular surface squamous neoplasia: current status.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19776089.
- Also identified by DOI 10.1136/bjo.2009.160820.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although there are no randomised trials directly comparing topical chemotherapeutic agents mitomycin-C, 5-fluorouracil, and interferon-alpha2b, published studies indicate equal efficacy of these agents for treatment of non-invasive ocular surface squamous neoplasia (80%-88%). 5-Fluorouracil may be preferred, given low incidence of serious side effects and low cost to the patient.
Medical subject headings
- Antineoplastic Agents
- Eye Neoplasms
- Neoplasms, Squamous Cell